Clinical Trial Update: Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) [Phase 3]

View source ↗

Summary

Phase 3 trial FLUTE-2 evaluating efficacy and safety of APT-1011 in adults with eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• APT-1011

Snippet

Sponsor: Ellodi Pharmaceuticals, LP | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED